Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-01-28 @ 6:14 PM
Study NCT ID:
NCT00774202
Status:
COMPLETED
Last Update Posted:
2019-01-09
First Post:
2008-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
Sponsor:
Weill Medical College of Cornell University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0301005964
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None